The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 30, 2014
Filed:
Oct. 18, 2011
Applicant:
David S. Garvey, Dover, MA (US);
Inventor:
David S. Garvey, Dover, MA (US);
Assignee:
Nicox, S.A., Sophia Antipolis, FR;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5377 (2006.01); A61K 31/4523 (2006.01); A61K 31/41 (2006.01); A61K 31/4245 (2006.01); A61K 31/4035 (2006.01); A61K 31/535 (2006.01); C07D 233/02 (2006.01); C07D 271/08 (2006.01); C07D 263/06 (2006.01); C07D 265/06 (2006.01); C07D 211/94 (2006.01); C07D 209/46 (2006.01); C07D 207/46 (2006.01);
U.S. Cl.
CPC ...
C07D 271/08 (2013.01); C07D 233/02 (2013.01); C07D 263/06 (2013.01); C07D 265/06 (2013.01); C07D 211/94 (2013.01); C07D 209/46 (2013.01); C07D 207/46 (2013.01);
Abstract
The invention provides methods for treating ophthalmic disorders comprising at least one nitric oxide enhancing prostaglandin compound or a pharmaceutically acceptable salt thereof, and, optionally, at least one nitric oxide enhancing compound and/or at least one therapeutic agent. The nitric oxide enhancing prostaglandin compounds comprise at least one heterocyclic nitric oxide donor group and/or at least one nitroxide group.